Capnia (NASDAQ: SLNO) is one of 81 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it compare to its rivals? We will compare Capnia to related businesses based on the strength of its risk, profitability, earnings, institutional ownership, analyst recommendations, dividends and valuation.
This is a breakdown of recent recommendations and price targets for Capnia and its rivals, as reported by MarketBeat.
||Strong Buy Ratings
Capnia currently has a consensus target price of $25.00, indicating a potential upside of 1,648.25%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 5.94%. Given Capnia’s stronger consensus rating and higher probable upside, research analysts plainly believe Capnia is more favorable than its rivals.
Valuation and Earnings
This table compares Capnia and its rivals gross revenue, earnings per share (EPS) and valuation.
Capnia’s rivals have higher revenue and earnings than Capnia. Capnia is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Institutional and Insider Ownership
65.6% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 69.8% of Capnia shares are held by company insiders. Comparatively, 12.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
This table compares Capnia and its rivals’ net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Risk and Volatility
Capnia has a beta of 5.99, suggesting that its stock price is 499% more volatile than the S&P 500. Comparatively, Capnia’s rivals have a beta of 0.93, suggesting that their average stock price is 7% less volatile than the S&P 500.
Capnia rivals beat Capnia on 7 of the 12 factors compared.
Capnia Company Profile
Soleno Therapeutics, Inc., formerly Capnia, Inc., is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief. The Company has developed the CoSense End-Tidal Carbon Monoxide Monitor that measures ETCO for the detection of dangerous hemolysis rates. The Infant Solutions product line, including the NeoPIP Infant Resuscitator Unit and accessories, is designed for controlled and accurate resuscitation of neonates and infants in the clinical environment. Serenz Nasal Relief is a hand-held nasal irrigator that uses carbon dioxide (CO2) gas to wash the nasal passages.
Receive News & Ratings for Capnia Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc. and related companies with MarketBeat.com's FREE daily email newsletter.